160 related articles for article (PubMed ID: 29618488)
1. SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects.
Potter BVL
J Mol Endocrinol; 2018 Aug; 61(2):T233-T252. PubMed ID: 29618488
[TBL] [Abstract][Full Text] [Related]
2. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the development of steroid sulphatase inhibitors.
Purohit A; Hejaz HA; Woo LW; van Strien AE; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 1999; 69(1-6):227-38. PubMed ID: 10418996
[TBL] [Abstract][Full Text] [Related]
4. The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates.
Chander SK; Purohit A; Woo LW; Potter BV; Reed MJ
Biochem Biophys Res Commun; 2004 Sep; 322(1):217-22. PubMed ID: 15313194
[TBL] [Abstract][Full Text] [Related]
5. Steroid sulphatase inhibitors for breast cancer therapy.
Purohit A; Woo LW; Chander SK; Newman SP; Ireson C; Ho Y; Grasso A; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):423-32. PubMed ID: 14623540
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate.
Raobaikady B; Purohit A; Chander SK; Woo LW; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):351-8. PubMed ID: 12711022
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
Thomas MP; Potter BV
J Med Chem; 2015 Oct; 58(19):7634-58. PubMed ID: 25992880
[TBL] [Abstract][Full Text] [Related]
8. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity.
Purohit A; Vernon KA; Hummelinck AE; Woo LW; Hejaz HA; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):269-75. PubMed ID: 9618028
[TBL] [Abstract][Full Text] [Related]
9. Steroid Sulphatase and Its Inhibitors: Past, Present, and Future.
Foster PA
Molecules; 2021 May; 26(10):. PubMed ID: 34064842
[TBL] [Abstract][Full Text] [Related]
10. The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells.
Purohit A; Dauvois S; Parker MG; Potter BV; Williams GJ; Reed MJ
J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):101-4. PubMed ID: 8049127
[TBL] [Abstract][Full Text] [Related]
11. In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate.
Purohit A; Williams GJ; Roberts CJ; Potter BV; Reed MJ
Int J Cancer; 1995 Sep; 63(1):106-11. PubMed ID: 7558436
[TBL] [Abstract][Full Text] [Related]
12. 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor.
Reed JE; Woo LW; Robinson JJ; Leblond B; Leese MP; Purohit A; Reed MJ; Potter BV
Biochem Biophys Res Commun; 2004 Apr; 317(1):169-75. PubMed ID: 15047163
[TBL] [Abstract][Full Text] [Related]
13. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
Thomas MP; Potter BV
J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
[TBL] [Abstract][Full Text] [Related]
14. Steroid sulphatase: expression, isolation and inhibition for active-site identification studies.
Purohit A; Potter BV; Parker MG; Reed MJ
Chem Biol Interact; 1998 Feb; 109(1-3):183-93. PubMed ID: 9566745
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates.
Malini B; Purohit A; Ganeshapillai D; Woo LW; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):253-8. PubMed ID: 11282279
[TBL] [Abstract][Full Text] [Related]
16. New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1
Ciupak O; Daśko M; Biernacki K; Rachon J; Masłyk M; Kubiński K; Martyna A; Demkowicz S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):238-247. PubMed ID: 33322953
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and steroid sulphatase inhibitory activity of C19- and C21-steroidal derivatives bearing a benzyl-inhibiting group.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
Eur J Med Chem; 2001; 36(7-8):659-71. PubMed ID: 11600235
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in the development of steroid sulphatase inhibitors - examples of the novel and most promising compounds from the last decade.
Daśko M; Demkowicz S; Biernacki K; Ciupak O; Kozak W; Masłyk M; Rachon J
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1163-1184. PubMed ID: 32363947
[TBL] [Abstract][Full Text] [Related]
19. Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism.
Woo LW; Lightowler M; Purohit A; Reed MJ; Potter BV
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):79-88. PubMed ID: 8645620
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of steroid sulphatase activity by steroidal methylthiophosphonates: potential therapeutic agents in breast cancer.
Purohit A; Howarth NM; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):523-7. PubMed ID: 8180114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
